Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases

1 Oct 2021

Abstract excerpt

Abstract Neurosecretory protein VGF (non-acronymic) belongs to the granin family of neuropeptides. VGF and VGF-derived peptides have been repeatedly identified in well-powered and well-designed multi-omic studies as dysregulated in neurodegenerative and psychiatric diseases. New therapeutics is urgently needed for these devastating and costly diseases, as are new biomarkers to improve disease diagnosis and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neuropeptides and Animal Physiology
Share to Protein Hydrolysis and Bioactive Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34778762
DOI: 10.1093/braincomms/fcab261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseasesPMID 34778762Read ↗

The emerging role of furin in neurodegenerative and neuropsychiatric diseasesSemantic proximity Read ↗

Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological DisordersSemantic proximity Read ↗

SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease PatientsSemantic proximity Read ↗

Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomicsSemantic proximity Read ↗

Extracellular Vesicles for Alzheimer’s Disease and Dementia DiagnosisSemantic proximity Read ↗

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseSemantic proximity Read ↗

VGF in cerebrospinal fluid, when combined with conventional biomarkers, enhances prediction of conversion from mild cognitive impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.Semantic proximity Read ↗

Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction with Neurodegenerative DiseasesSemantic proximity Read ↗

Long Covid and Neurodegenerative DiseaseSemantic proximity Read ↗

Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer’s diseaseSemantic proximity Read ↗

Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.